OTC: FAMDF - Futura Medical plc

半年間の収益性: -65.91%
配当利回り: 0.00%
セクタ: Healthcare

プロモーションスケジュール Futura Medical plc


会社について Futura Medical plc

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.


Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета gbp
Сайт https://www.futuramedical.com
Цена ао 0.19
1日あたりの価格変動: 0% (0.15)
週ごとの価格変動: 0% (0.15)
月ごとの料金変更: -21.05% (0.19)
3ヶ月間の価格変動: -61.54% (0.39)
半年間の価格変動: -65.91% (0.44)
年間の価格変動: -64.29% (0.42)
3年間の価格推移: -53.13% (0.32)
5年間の価格推移: +15.38% (0.13)
年初からの価格変動: -60.53% (0.38)

過小評価

名前 意味 学年
P/S 23.16 1
P/BV 13.11 1
P/E 0 0
EV/EBITDA -9.38 0
合計: 1.63

効率

名前 意味 学年
ROA, % -55.09 0
ROE, % -118.86 0
合計: 0

配当金

名前 意味 学年
Div yield, % 0 0
DSI 0 0
合計: 0

義務

名前 意味 学年
Debt/EBITDA 0 10
合計: 9.2

成長の衝動

名前 意味 学年
収益性 Revenue, % 10420.31 10
収益性 Ebitda, % -38.67 0
収益性 EPS, % -51.22 0
合計: 2



スーパーバイザー 役職 支払い 生年
Mr. James Henry Barder CEO & Executive Director 503.84k 1959 (66 年)
Ms. Angela Hildreth COO, Finance Director, Company Secretary & Executive Director 394.36k 1980 (45 年)
Mr. Kenneth William James Head of R&D & Executive Director 361.11k 1952 (73 年)
Dr. William Duncan Potter Chief Scientific Officer & Adviser to the Board N/A 1948 (77 年)
Graham Smith Head of Alliance Partnerships & Supply N/A
Kevin Langridge Head of Quality N/A

住所: United Kingdom, Guildford, Surrey Technology Centre - Googleマップで開く, Yandexマップを開く
Webサイト: https://www.futuramedical.com